🇺🇸 FDA
Pipeline program

BL-B01D1

BL-B01D1-204-11

Phase 2 small_molecule active

Quick answer

BL-B01D1 for Cervical Cancer is a Phase 2 program (small_molecule) at Sichuan Baili Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Sichuan Baili Pharmaceutical Co.,
Indication
Cervical Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials